Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers

--News Direct--

Proactive Investors USA

Proactive Investors USA

+1 347-449-0879

na-editorial@proactiveinvestors.com

View original content to download multimedia: https://newsdirect.com/news/context-therapeutics-announces-bispecific-antibody-clinical-candidate-to-treat-cldn6-cancers-478676962